BRCA1 and neoplasm: Here, we used an isogenic Brca1 murine mammary epithelial cell (MMEC) model to examine the specific effect of loss of Brca1 on cellular sensitivity to various chemotherapeutic agents in a manner beyond that achievable in less well-characterized human tumor cell lines.